Berns Paul L

Allos Therapeutics, Inc.

Chief Executive Officer

Avg. Two Year Performance

130% Avg. Purchase Return 52% Compound

(< 1%) Avg. Sale Return 0% Compound

Holdings: 0 shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Other

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions